The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index.
Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
Open accessAbstract
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a multi-center study assessing neuroimaging in diagnosis and longitudinal monitoring. Amnestic Mild Cognitive Impairment (MCI) often represents a prodromal form of dementia, conferring a 10-15% annual risk of converting to probable AD. We analyzed baseline 1.5T MRI scans in 693 participants from the ADNI cohort divided into four groups by baseline diagnosis and one year MCI to probable AD conversion status to identify neuroimaging phenotypes associated with MCI and AD and potential predictive markers of imminent conversion. MP-RAGE scans were analyzed using publicly available voxel-based morphometry (VBM) and automated parcellation methods. Measures included global and hippocampal grey matter (GM) density, hippocampal and amygdalar volumes, and cortical thickness values from entorhinal cortex and other temporal and parietal lobe regions. The overall pattern of structural MRI changes in MCI (n=339) and AD (n=148) compared to healthy controls (HC, n=206) was similar to prior findings in smaller samples. MCI-Converters (n=62) demonstrated a very similar pattern of atrophic changes to the AD group up to a year before meeting clinical criteria for AD. Finally, a comparison of effect sizes for contrasts between the MCI-Converters and MCI-Stable (n=277) groups on MRI metrics indicated that degree of neurodegeneration of medial temporal structures was the best antecedent MRI marker of imminent conversion, with decreased hippocampal volume (left > right) being the most robust. Validation of imaging biomarkers is important as they can help enrich clinical trials of disease modifying agents by identifying individuals at highest risk for progression to AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. (4). Extracted GM density, volume, and cortical thickness values from medial temporal lobe structures. Comparisons of GM density values (A) were extracted from the unmodulated VBM GM maps using standard left and right hippocampal ROIs traced on an independent sample of 40 HC participants [25, 58]. Bilateral hippocampal (B) and amygdalar (C) volume estimates and entorhinal cortex thickness values (D) were extracted using automated parcellation. The comparisons of all four MRI metrics show a significant difference (p<0.001) across all groups. In pairwise comparisons, hippocampal GM density, hippocampal and amygdala volumes, and entorhinal cortex thickness show significant differences between HC and all clinical groups (p<0.001) bilaterally and MCI-Stable and AD groups (p<0.001) bilaterally. Furthermore, MCI-Stable and MCI-Converter groups show significant differences in GM density and volume in the left (GM (A), p=0.001; volume (B), p<0.001) and right (GM (A), p=0.034; volume (B), p<0.001) hippocampi, as well as significant differences in amygdala volume on both the left (p<0.001) and right (p=0.01). MCI-Converters also showed significantly thinner entorhinal cortices than MCI-Stable participants on both the left (p=0.006) and right (p<0.001). No significant differences were found in hippocampal GM density, hippocampal or amygdalar volumes, or entorhinal cortex thickness values between MCI-Converter and AD groups. Age, gender, years of education, handedness, and ICV were included as covariates in all comparisons.](/paper-figures/7b93948ff2074bee96839e69a1dee4b1/baseline-mri-predictors-of-conversion-from-mci-to-probable-ad-in-the-adni-cohort-figure-4.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“a large number of novel loci and genes have been nominated by these analyses [222, 229–231]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [222]
Experimental — accuracy not yet measuredIn the citing paper
“they reliably predict cognitive decline [222]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [222]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Cortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Sheikh (1986) · doi:10.1300/j018v05n01_09 · Cited by 7,236
Cortical Surface-Based Analysis
Fischl, B., Sereno, M. I., & Dale, A. M. (1999) · NeuroImage · doi:10.1006/nimg.1998.0396 · Cited by 6,147
Measuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B. R., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,995
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336
A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N. A., Friston, K. J., & Frackowiak, R. S. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0786 · Cited by 4,561
Kaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
L’examen Clinique en Psychologie
Rubé, P. (1959) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1959.13.4.989 · Cited by 3,299
Measurement of Functional Activities in Older Adults in the Community
PFEFFER, R. I., Kurosaki, T., Harrah, C. H., Chance, J. M., & Filos, S. (1982) · Journal of Gerontology · doi:10.1093/geronj/37.3.323 · Cited by 2,978
Validation of the NPI-Q, a Brief Clinical Form of the Neuropsychiatric Inventory
Kaufer, D., Cummings, J. L., Ketchel, P., Smith, V. M., MacMillan, A., Shelley, T., López, O. L., & DeKosky, S. T. (2000) · Journal of Neuropsychiatry · doi:10.1176/jnp.12.2.233 · Cited by 1,978
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
The Alzheimer's Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.008 · Cited by 1,525
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
Pathological verification of ischemic score in differentiation of dementias
Rosen, W. G., Terry, R. D., Fuld, P. A., Katzman, R., & Peck, A. (1980) · Annals of Neurology · doi:10.1002/ana.410070516 · Cited by 1,273
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
Jack, C. R., Petersen, R. C., Xu, Y. C., Waring, S. C., O'Brien, P. C., Tangalos, E. G., Smith, G. E., Ivnik, R. J., & Kokmen, E. (1997) · Neurology · doi:10.1212/wnl.49.3.786 · Cited by 1,128
Jack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, E. G., & Kokmen, E. (2000) · Neurology · doi:10.1212/wnl.55.4.484 · Cited by 937
Voxel-Based Morphometry of the Human Brain: Methods and Applications
Mechelli, A., Price, C. J., Friston, K. J., & Ashburner, J. (2005) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405054038726 · Cited by 894
Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
Jack, C. R., Shiung, M. M., Gunter, J. L., O’Brien, P. C., Weigand, S. D., Knopman, D. S., Boeve, B. F., Ivnik, R. J., Smith, G. E., Cha, R. H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000110315.26026.ef · Cited by 827 · cited 3×
“Additional information, including changes in imaging measures over time and rate of atrophy, has been shown to be useful in assessing and accurately predicting rapid conversion [41, 42].”
BackgroundHippocampal and entorhinal atrophy in mild cognitive impairment
Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., Santi, S. D., Segal, S., Rusinek, H., Pelton, G. H., Honig, L. S., Mayeux, R. P., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256697.20968.d7 · Cited by 749
In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease
Baron, J., Chételat, G., Desgranges, B., Perchey, G., Landeau, B., Sayette, V. D. L., & Eustache, F. (2001) · NeuroImage · doi:10.1006/nimg.2001.0848 · Cited by 699
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
Mormino, E. C., Kluth, J. T., Madison, C. M., Rabinovici, G. D., Baker, S. L., Miller, B. L., Koeppe, R. A., Mathis, C. A., Weiner, M. W., Jagust, W. J., et al. (2009) · Brain · doi:10.1093/brain/awn320 · Cited by 684
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease
Jack, C. R., Petersen, R. C., Xu, Y., O'Brien, P. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1998) · Neurology · doi:10.1212/wnl.51.4.993 · Cited by 666
Mini-Mental State Examination (MMSE)
Gauthier, S. G. (2001) · CRC Press eBooks · doi:10.3109/9780203213896-22 · Cited by 663
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease
Karas, G. B., Scheltens, P., Rombouts, S. A. R. B., Visser, P. J., van Schijndel, R. A., Fox, N. C., & Barkhof, F. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.006 · Cited by 613
Whitwell, J. L., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2007) · Brain · doi:10.1093/brain/awm112 · Cited by 607
Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI
Saykin, A. J., Wishart, H. A., Rabin, L. A., Santulli, R. B., Flashman, L. A., West, J. D., McHugh, T., & Mamourian, A. C. (2006) · Neurology · doi:10.1212/01.wnl.0000234032.77541.a2 · Cited by 594
Self-citationConversion of Mild Cognitive Impairment to Alzheimer Disease Predicted by Hippocampal Atrophy Maps
Apostolova, L. G., Dutton, R. A., Dinov, I. D., Hayashi, K. M., Toga, A. W., Cummings, J. L., & Thompson, P. M. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.693 · Cited by 553
MISRA, C., FAN, Y., & DAVATZIKOS, C. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.031 · Cited by 552
The Magnitude of Dementia Occurrence in the World
Wimo, A. B., Winblad, B. G., Agüero‐Torres, H., & Strauss, E. I. V. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200304000-00002 · Cited by 536
Chételat, G., Landeau, B., Eustache, F., Mézenge, F., Viader, F., de la Sayette, V., Desgranges, B., & Baron, J.-C. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.015 · Cited by 526
Hansen, R. A., Webb, A. P., Moore, C. G., Gartlehner, G., Jonas, D. E., & Morgan, L. C. (2020) · PubMed Central · doi:10.17615/ae8c-2p76 · Cited by 523
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI
Jack, C. R., Shiung, M. M., Weigand, S. D., O’Brien, P. C., Gunter, J. L., Boeve, B. F., Knopman, D. S., Smith, G. E., Ivnik, R. J., Tangalos, E. G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000180958.22678.91 · Cited by 492
Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia
Du, A., Schuff, N. W., Kramer, J. H., Rosen, H. J., Gorno‐Tempini, M. L., Rankin, K. P., Miller, B. L., & Weiner, M. W. (2006) · Brain · doi:10.1093/brain/awm016 · Cited by 491
Fan, Y., Batmanghelich, N., Clark, C. M., & Davatzikos, C. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.10.031 · Cited by 477
Karas, G. B., Burton, E. J., Rombouts, S. A. R. B., van Schijndel, R. A., O'Brien, J. T., Scheltens, P., McKeith, I. G., Williams, D. M., Ballard, C. G., & Barkhof, F. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00041-7 · Cited by 418
Good, C. D., Scahill, R. I., Fox, N. C., Ashburner, J., Friston, K. J., Chan, D., Crum, W. R., Rossor, M. N., & Frackowiak, R. S. J. (2002) · NeuroImage · doi:10.1006/nimg.2002.1202 · Cited by 415
Devanand, D. P., Liu, X., Tabert, M. H., Pradhaban, G., Cuasay, K., Bell, K. L., de Leon, M. J., Doty, R. L., Stern, Y., & Pelton, G. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.020 · Cited by 413
A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment
on behalf of the Rofecoxib Protocol 078 study group, Thal, L. J., Ferris, S. H., Kirby, L., Block, G. A., Lines, C. R., Yuen, E., Assaid, C., Nessly, M. L., Norman, B. A., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300690 · Cited by 402 · cited 1×
“Pharmacological treatments, such as AChE inhibitors and memantine, have been shown to reduce or delay MCI to AD conversion [83-87].”
BackgroundDetection of grey matter loss in mild Alzheimer's disease with voxel based morphometry
Frisoni, G. B. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.657 · Cited by 393
Hua, X., Leow, A., Parikshak, N., Lee, S., Chiang, M.-C., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.07.013 · Cited by 372
Visser, P. J., Verhey, F. R. J., Hofman, P. A. M., Scheltens, P., & Jolles, J. (2002) · PubMed Central · doi:10.1136/jnnp.72.4.491 · Cited by 359
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment
Whitwell, J. L., Shiung, M. M., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2008) · Neurology · doi:10.1212/01.wnl.0000280575.77437.a2 · Cited by 357
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment
Korf, E. S. C., Wahlund, L., Visser, P. J., & Scheltens, P. (2004) · Neurology · doi:10.1212/01.wnl.0000133114.92694.93 · Cited by 348
MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD
deToledo‐Morrell, L., Stoub, T. R., Bulgakova, M., Wilson, R. S., Bennett, D. A., Leurgans, S. E., Wuu, J., & Turner, D. A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.007 · Cited by 330
Voxel-based morphometry to discriminate early Alzheimer's disease from controls
Hirata, Y., Matsuda, H., Nemoto, K., Ohnishi, T., Hirao, K., Yamashita, F., Asada, T., Iwabuchi, S., & Samejima, H. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.038 · Cited by 329
Efficacy of donepezil in mild cognitive impairment
Salloway, S., Ferris, S. H., Kluger, A., Goldman, R. S., Griesing, T., Kumar, D., & Richardson, S. (2004) · Neurology · doi:10.1212/01.wnl.0000134664.80320.92 · Cited by 301
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD
Jack, C. R., Slomkowski, M., Gracon, S. I., Hoover, T. M., Felmlee, J. P., Stewart, K., Xu, Y., Shiung, M. S., O’Brien, P. C., Cha, R., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000042480.86872.03 · Cited by 297
Olivier Colliot, A., Chételat, G., Marie Chupin, A., Desgranges, B., Magnin, B., Benali, H., Dubois, B., Garnero, L., Eustache, F., & Lehéricy, S. (2008) · Radiology · doi:10.1148/radiol.2481070876 · Cited by 294
Synphilin-1 is present in Lewy bodies in Parkinson's disease
Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A., & Takahashi, H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 269
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease
Apostolova, L. G., Dinov, I. D., Dutton, R. A., Hayashi, K. M., Toga, A. W., Cummings, J. L., & Thompson, P. M. (2006) · Brain · doi:10.1093/brain/awl274 · Cited by 251
MRI and CSF studies in the early diagnosis of Alzheimer's disease
de Leon, M. J., DeSanti, S., Zinkowski, R. P., Mehta, P. D., Praticò, D., Segal, S., Clark, C. M., Kerkman, D. J., DeBernardis, J. F., Li, J., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01381.x · Cited by 226
A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer’s disease
Busatto, G. F., Garrido, G. E. J., Almeida, O. P., de Castro, C. C., de Camargo, C. H. P., Cid, C. G., Buchpiguel, C. A., Furuie, S. S., & Bottino, C. M. D. C. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00084-2 · Cited by 221
A voxel based morphometry study on mild cognitive impairment
Pennanen, C. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.035600 · Cited by 218
Teipel, S. J., Born, C., Ewers, M., Bokde, A. L. W., Reiser, M. F., Möller, H., & Hampel, H. J. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.07.008 · Cited by 204
Morra, J. H., Tu, Z., Apostolova, L. G., Green, A. E., Avedissian, C., Madsen, S. K., Parikshak, N., Hua, X., Toga, A. W., Jack, C. R., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.07.003 · Cited by 202
Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease
de Leon, M. J., Mosconi, L., Blennow, K., DeSanti, S., Zinkowski, R. P., Mehta, P. D., Praticò, D., Tsui, W., Louis, L. A. S., Sobanska, L., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.012 · Cited by 200
MRI predictors of risk of incident Alzheimer disease
Stoub, T. R., Bulgakova, M., Leurgans, S. E., Bennett, D. A., Fleischman, D. A., Turner, D. A., & deToledo‐Morrell, L. (2005) · Neurology · doi:10.1212/01.wnl.0000160089.43264.1a · Cited by 193
KHAN, A. R., Wang, L., & Beg, M. F. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.024 · Cited by 182
CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment
Bouwman, F. H., Schoonenboom, S. N. M., van der Flier, W. M., van Elk, E. J., Kok, A., Barkhof, F., Blankenstein, M. A., & Scheltens, P. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.006 · Cited by 182
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment
Fleisher, A., Sun, S., Taylor, C., Ward, C., Gamst, A. C., Petersen, R. C., Jack, C. R., Aisen, P. S. S., & Thal, L. J. (2008) · Neurology · doi:10.1212/01.wnl.0000287091.57376.65 · Cited by 180
The contribution of voxel-based morphometry in staging patients with mild cognitive impairment
Bozzali, M., Filippi, M., Magnani, G., Cercignani, M., Franceschi, M., Schiatti, E., Castiglioni, S., Mossini, R., Falautano, M., Scotti, G., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000228243.56665.c2 · Cited by 180
Karas, G. B., Sluimer, J. D., Goekoop, R., van der Flier, W. M., Rombouts, S. A. R. B., Vrenken, H., Scheltens, P., Fox, N. C., & Barkhof, F. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0949 · Cited by 173
MRI of hippocampus and entorhinal cortex in mild cognitive impairment: A follow-up study
Tapiola, T., Pennanen, C., Tapiola, M., Tervo, S., Kivipelto, M., Hänninen, T., Pihlajamaki, M. M., Laakso, M. P., Hallikainen, M., Hämäläinen, A., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.007 · Cited by 169
Tanna, N. K., Kohn, M., Horwich, D., Jolles, P. R., Zimmerman, R. A., Alves, W. M., & Alavi, A. (1991) · Radiology · doi:10.1148/radiology.178.1.1984290 · Cited by 148
Volumetric MRI and cognitive measures in Alzheimer disease
Ridha, B. H., Anderson, V. M., Barnes, J., Boyes, R. G., Price, S. L., Rossor, M. N., Whitwell, J. L., Jenkins, L., Black, R. S., Grundman, M., et al. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0750-9 · Cited by 145
Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment
Hämäläinen, A., Tervo, S., Grau-Olivares, M., Niskanen, E. I., Pennanen, C., Huuskonen, J., Kivipelto, M., Hänninen, T., Tapiola, M., Vanhanen, M., et al. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.06.016 · Cited by 142
Modrego, P. J. (2006) · Current Alzheimer Research · doi:10.2174/156720506776383103 · Cited by 105
Eckerström, C., Olsson, E., Borga, M., EKHOLM, S. E., Ribbelin, S., Rolstad, S., Starck, G., Edman, Å., Wallin, A., & Malmgren, H. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.04.024 · Cited by 88
Prediction of Alzheimer's disease in mild cognitive impairment: A prospective study in Taiwan
Wang, P. N., Lirng, J. F., Lin, K. N., Chang, F., & Liu, H. C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.002 · Cited by 74
VBM anticipates the rate of progression of Alzheimer disease
Kinkingnéhun, S., Sarazin, M., Lehéricy, S., Guichart-Gomez, E., Hergueta, T., & Dubois, B. (2008) · Neurology · doi:10.1212/01.wnl.0000303960.01039.43 · Cited by 72
Mini-Mental State Examination (MMSE)
Shahid, A., Wilkinson, K., Marcu, S., & Shapiro, C. M. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9893-4_51 · Cited by 58
Trivedi, M. A., Wichmann, A. K., Torgerson, B. M., Ward, M. A., Schmitz, T. W., Ries, M. L., Koscik, R. L., Asthana, S., & Johnson, S. C. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.06.001 · Cited by 46
Hippocampal Volume and Shape Analysis in an Older Adult Population
McHugh, T., Saykin, A. J., Wishart, H. A., Flashman, L. A., Cleavinger, H. B., Rabin, L. A., Mamourian, A. C., & Shen, L. (2007) · The Clinical Neuropsychologist · doi:10.1080/13854040601064534 · Cited by 39
Self-citationHämäläinen, A., Grau-Olivares, M., Tervo, S., Niskanen, E. I., Pennanen, C., Huuskonen, J., Kivipelto, M., Hänninen, T., Tapiola, M., Vanhanen, M., et al. (2008) · Neurodegenerative Diseases · doi:10.1159/000113698 · Cited by 33
Hippocampal and entorhinal atrophy in mild cognitive impairment: Prediction of Alzheimer disease
Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., De Santi, S., Segal, S., Rusinek, H., Pelton, G. H., Honig, L. S., Mayeux, R. P., et al. (2022) · Columbia Academic Commons (Columbia University) · doi:10.7916/qbbr-9x61 · Cited by 30
Klauschen, F., Angermann, B. R., & Meier‐Schellersheim, M. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03472.x · Cited by 16
Sabbagh, M. N., Richardson, S., & Relkin, N. R. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.11.013 · Cited by 15
Shen, L., Saykin, A. J., Firpi, H. A., West, J. D., McHugh, T., Wishart, H. A., Flashman, L. A., Wessels, A. M., McDonald, B. C., & Cannon, A. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.1150 · Cited by 3
Self-citation
Research works printed but not linked: 1
- [35]Dickerson BC Goncharova I Sullivan MP Forchetti C Wilson RS Bennett DA MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease Neurobiol Aging 2001 22 747 754 11705634
Cited by
Sorted by citations
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Weiner, M. W., Veitch, D. P., Aisen, P. S. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Liu, E., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.1769 · Cited by 1,033
Self-citationSmith, A. D., Smith, S. M., de Jager, C. A., Whitbread, P., Johnston, C., Agacinski, G., Oulhaj, A., Bradley, K. M., Jacoby, R., & Refsum, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012244 · Cited by 813
“An intermediate rate of atrophy is found in people with mild cognitive impairment (MCI) [6,7,8,9,10,11].”
A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease
Laxton, A. W., Tang‐Wai, D. F., McAndrews, M. P., Zumsteg, D., Wennberg, R. A., Keren, R., Wherrett, J. R., Naglie, G., Hamani, C., Smith, G. S., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22089 · Cited by 827
Multimodal Neuroimaging Feature Learning for Multiclass Diagnosis of Alzheimer's Disease
Liu, S., Liu, S., Cai, W., Che, H., Pujol, S., Kikinis, R., Feng, D., Fulham, M. J., & ADNI (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2014.2372011 · Cited by 637
Metadata
- Authors
- Risacher, S., Saykin, A., Wes, J., Shen, L., Firpi, H., & McDonald, B.
- Affiliations
- Indiana University School of Medicine (US)
- Indiana University Bloomington (US)
- Corresponding author
- Saykin, Andrew
- Venue
- Current Alzheimer Research
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-08-01
- Volume
- 6
- Issue
- 4
- Pages
- 347-361
- ISSN
- 1567-2050 (ISSN-L)
- PMC
- PMC2764863
- OpenAlex
- W2128422359
- Cited by
- 538
- References
- 90
- Citations by year
- 2026: 18 · 2025: 11 · 2024: 21 · 2023: 23 · 2022: 20 · 2021: 29 · 2020: 39 · 2019: 36 · 2018: 44 · 2017: 38 · 2016: 41 · 2015: 29 · 2014: 31 · 2013: 46 · 2012: 33
- FWCI
- 22.68
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Current Alzheimer Research (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- Funders
- Brigham Young University
- National Institutes of Health (5u01ag024904-10)
- School of Medicine, Indiana University
- National Institute on Aging (U01-AG-024904, P30AG010133, R01 AG19771, R01AG019771, U19AG010483, P30 AG-10133)
- National Institute of Biomedical Imaging and Bioengineering (R03EB008674)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, amnestic mild cognitive impairment, neuroimaging biomarkers, hippocampal volume, gray matter density, amygdala, entorhinal cortex, cortical thickness, medial temporal lobe atrophy, structural MRI, voxel-based morphometry, MPRAGE, disease progression prediction
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Analysis of Variance, Atrophy, Brain Mapping, Cerebral Cortex, Cognition Disorders, Female, Hippocampus, Humans, Image Interpretation, Computer-Assisted, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Organ Size, Predictive Value of Tests, Multivariate Analysis, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review